Enanta Pharmaceuticals, Inc. (ENTA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 255.39M |
| Enterprise Value | 424.15M |
| P/E Ratio | -5.38 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 5.77 |
| Price/Book Ratio | 3.73 |
| Enterprise/Revenue | 6.12 |
| Enterprise/EBITDA | -8.58 |
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.97 |
| Operating Margin | -0.9 |
| Return On Assets | -0.21 |
| Return On Equity | -0.62 |
| Revenue | 65.32M |
| Revenue/Share | 2.24 |
| Gross Profit | 60.74M |
| EBITDA | -70.78M |
| Net Income | -81.89M |
| Diluted EPS | -3.84 |
| Total Cash | 189.51M |
| Total Cash/Share | 6.51 |
| Total Debt | 55.66M |
| Total Debt/Equity | 0.55 |
| Current Ratio | 3.76 |
| Book Value Per Share | 3.47 |
| 52-Week Change | 56.52 |
| 52-Week High | 17.15 |
| 52-Week Low | 7.05 |
| Moving Average 50 Days | 13.5 |
| Moving Average 200 Days | 13.62 |
| Average Volume | 218,612 |
| Shares Outstanding | 29.08M |
| % Held by Institutions | 94.75 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |